Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ctDNA-Guided Therapy Cessation

Ellen Langedijk

MD, PhD

🏢Netherlands Cancer Institute🌐Netherlands

Clinical Research Fellow, Oncology

14
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ellen Langedijk at the Netherlands Cancer Institute investigates ctDNA-guided de-escalation of cancer therapy, exploring whether undetectable ctDNA can safely guide early treatment discontinuation without compromising outcomes. Her clinical research has focused on breast and colorectal cancer settings where over-treatment is a significant concern. Her work contributes to the emerging paradigm of biology-driven treatment duration decisions.

Share:

🧪Research Fields 研究领域

ctDNA-guided therapy de-escalation
treatment cessation liquid biopsy
breast cancer ctDNA monitoring
ctDNA response assessment
biomarker-driven treatment stop

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ellen Langedijk 的研究动态

Follow Ellen Langedijk's research updates

留下邮箱,当我们发布与 Ellen Langedijk(Netherlands Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment